Effect of chronic paroxetine treatment on 5-HT1B and 5-HT1D autoreceptors in rat dorsal raphe nucleus

被引:18
|
作者
Davidson, C [1 ]
Stamford, JA [1 ]
机构
[1] Royal London Hosp, St Bartholomews & Royal London Sch Med & Dent, Acad Dept Anaesthesia & Intens Care, Neurotransmiss Lab, London E1 1BB, England
关键词
serotonin; fast cyclic voltammetry; dorsal raphe nucleus; 5-HT1B; 5-HT1D; 5-HT uptake; paroxetine; WAY; 100635;
D O I
10.1016/S0197-0186(99)00115-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study reports the effect of chronic paroxetine (10 mg/kg p.o., 21 days) on 5-HT1B and 5-HT1D autoreceptors controlling stimulated 5-HT efflux in slices of rat dorsal raphe nucleus. Electrically evoked 5-HT (10 pulses, 200 Hz, 0.1 ms, 10 mA) was measured using fast cyclic voltammetry. 5-HT efflux was inhibited by CP 93129 (10 nM-10 mu M) and by sumatriptan (1 nM-1 mu M) agonists at 5-HT1B and 5-HT1D receptors, respectively. Chronic paroxetine did not, initially, appear to alter the sensitivity of the 5-HT1B autoreceptors to CP 93129. However, when constructed in the presence of WAY 100635 (10 nM) the selective and silent 5-HT1A antagonist, there was a significant (P < 0.001) rightward shift of the CP 93129 concentration-response curve in the paroxetine-treated rats but not in the controls, implying a desensitisation of the 5-HT1B autoreceptor by paroxetine. Chronic paroxetine did not affect the sumatriptan concentration-response curve, even with WAY 100635 present, implying that there was no (de)sensitisation of the 5-HT1D autoreceptor. These data suggest that chronic paroxetine treatment may desensitise 5-HT1B autoreceptors in the dorsal raphe nucleus but that this effect is unmasked only when the dominant 5-HT1A autoreceptor control is antagonised. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 50 条
  • [21] Activation of serotonin 5-HT1B receptor in the dorsal raphe nucleus affects REM sleep in the rat
    Monti, Jaime M.
    Jantos, Hector
    Lagos, Patricia
    BEHAVIOURAL BRAIN RESEARCH, 2010, 206 (01) : 8 - 16
  • [22] 5-HT1A and 5-HT1B receptors control serotonin efflux in the rat median raphe nucleus in vitro
    Hopwood, SE
    Stamford, JA
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 20 - 20
  • [23] Viral gene transfer of 5-HT1B autoreceptors in rat dorsal raphe neurons alters fear potentiated startle
    Neumaier, JF
    Vincow, ES
    Clark, MS
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 19S - 19S
  • [24] ELECTROPHYSIOLOGICAL RESPONSES OF SEROTONINERGIC DORSAL RAPHE NEURONS TO 5-HT1A AND 5-HT1B AGONISTS
    SPROUSE, JS
    AGHAJANIAN, GK
    SYNAPSE, 1987, 1 (01) : 3 - 9
  • [25] [3H]5-HT binding to cloned human, dog, and rat 5-HT1D and 5-HT1B receptors
    Stanton, J
    Castro, L
    MacLeod, A
    Sternfeld, F
    Street, L
    Beer, M
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 266 - 266
  • [26] The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons
    Donaldson, C
    Boers, PM
    Hoskin, KL
    Zagami, AS
    Lambert, GA
    NEUROPHARMACOLOGY, 2002, 42 (03) : 374 - 385
  • [27] Exclusion of 5-HT1B and 5-HT1D serotonin receptor genes in migraine.
    Marttila, P
    Kallela, M
    Wessman, M
    Hartiala, J
    Färkkilä, M
    Kaprio, J
    Peltonen, L
    Palotie, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A460 - A460
  • [28] SB-272183, a selective 5-HT1A, 5-HT1B and 5-HT1D receptor antagonist.
    Roberts, C
    Watson, J
    Scott, C
    Collin, L
    Harries, MH
    Wyman, P
    Gaster, L
    Price, GW
    Midlemiss, DN
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U76 - U76
  • [29] Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus
    Neumaier, JF
    Root, DC
    Hamblin, MW
    NEUROPSYCHOPHARMACOLOGY, 1996, 15 (05) : 515 - 522
  • [30] The binding affinity and functional activity of eletriptan and other 5-HT1B/1D agonists at the human recombinant 5-HT1B and 5-HT1D receptors
    Stewart, M
    Napier, CM
    Katugampola, SD
    McHarg, AD
    Wallis, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 : U52 - U52